Status:

COMPLETED

Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment

Lead Sponsor:

Gilberto Cruz Arteaga

Collaborating Sponsors:

Coordinación de Investigación en Salud, Mexico

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The present study is designed for patients with mild COVID-19 phase, to demonstrate if there is a modification in the clinical evolution greater than or equal to 25% in their symptoms, implemented in ...

Detailed Description

Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potential fatal disease generating a global public health problem. Person-to-person transmission of COVID-...

Eligibility Criteria

Inclusion

  • Patients Eligible for Family Medicine Unit No.20 and Family Medicine Unit No.13 belonging to the North DF of the IMSS.
  • Male and female patients
  • Patients over 18 years of age.
  • Patients with compliance with the operational definition COVID-19 and confirmatory test of P.C.R. positive within the first days of the illness (that are evaluated in first level of medical attention).
  • Patients with comorbidities such as Type 2 Diabetes Mellitus, Systemic Arterial Hypertension, Overweight or Obesity.
  • That they agree to sign an informed consent
  • \- Related to Video Call:
  • That the Family Medicine Unit No.20 and the Family Medicine Unit No.13 belonging to the North DF of the IMSS have the Installation of Electronic Equipment for Internet use

Exclusion

  • Severe COVID-19 patients (Ameriten sent immediately to second level of care, hospital) Patients with any Personal Pathological History of Hematological Diseases. • Patients allergic to macrolides (Azithromycin) and Ivermectin.

Key Trial Info

Start Date :

December 16 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 25 2021

Estimated Enrollment :

114 Patients enrolled

Trial Details

Trial ID

NCT04673214

Start Date

December 16 2020

End Date

February 25 2021

Last Update

August 16 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Alma Italia Guerrero Martinez

Mexico City, Mexico City, Mexico, 02000

Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment | DecenTrialz